Table:
begin	end	state
1	4	cytoplasmic
5	5	non-cytoplasmic
6	6	cytoplasmic
7	39	transmembrane
40	44	non-cytoplasmic
45	50	cytoplasmic
51	77	transmembrane
78	79	cytoplasmic
80	86	non-cytoplasmic
87	98	cytoplasmic
99	111	transmembrane
112	138	cytoplasmic
139	162	transmembrane
163	173	non-cytoplasmic
174	195	transmembrane
196	220	cytoplasmic
221	243	transmembrane
244	248	non-cytoplasmic
249	267	transmembrane
268	279	cytoplasmic
280	302	transmembrane
303	322	non-cytoplasmic
323	351	transmembrane
352	362	cytoplasmic
363	389	transmembrane
390	408	non-cytoplasmic
409	430	transmembrane
431	435	cytoplasmic

Input:
>WP_010441630.1 NCBI__GCF_000192475.1:WP_010441630.1
MSLELITALYFLILFGILFMGLPVAFGLGGTAVLFALVFEPRALLSVPSAFYSTPWNSVL
VTVPLFLFMGSLIRFSGIAETAYDAVYKLIGHIHGGLAMGTVQVCTVFAAITGITPPATT
TMGQIAYPSMMRYKYDRRIAIGCIAAGGALGALIPPSVPFIFYGLLAKVSIGDLFMAGLL
PGLMLATFYTIYIGVRCKIQPELGPALPADQKFTRAEKLTAVLSIWPFALLIIIVLGVIW
GGIATPAEAAAFGAAGAFVINLIYGKLTWEVLKESLVSTLKLSGMGLWILIGATVYLNVF
NTLGSQDLLTNLVLSMPGGSTGILLMMMLIILVLGMVMDDWAIIMLCTPLFIPIIDELGI
DKLWFGALFIVNIQIAYLTPPFGFVLFWIKGVLPKDVSMGDVYNSVGPFVVLQFVGLTLI
FIFPQIATWLPSILK

Or try the official Phobius web server, which has a different display

Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server